Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NME Mid-Year Report: Approvals Might Near Record With Strong 2nd Half

Jul 07 2017

• By Michael Cipriano

FDA entrance sign 2016

Related Content

Do FDA Submission, Approval Declines Outside Cancer Signal Future Treatment Gaps?

Dec 15 2016

User Fee Extensions Are Key To CDER's First Cycle Review Success

Jan 18 2016

Novel Approvals Were Fewer But Faster At US FDA In 2016

Jan 02 2017

US FDA's Record-Breaking Month Of Breakthrough Therapy Designations

Jun 01 2017

Keeping Track: Cardio, Antibiotic Approvals Put FDA Over Last Year's Novel Drug Count

Jun 26 2017

Related Companies

Portola Pharmaceuticals, Inc.

TaiMed Biologics, Inc.

Theratechnologies Inc.

AbbVie Inc.

Gilead Sciences, Inc.

Pfizer Inc.

Additional Topics

United States Drug Review Regulation FDA Approvals BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.